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The renin–angiotensin system in the kidney plays a critical
role in the regulation of renal hemodynamics and sodium
handling through the activation of vascular, glomerular and
tubular angiotensin II type 1 (AT1) receptor-mediated
signaling. We previously cloned a molecule that specifically
bound to the AT1 receptor and modulated AT1 receptor
signaling in vitro, which we named ATRAP (for AT1
receptor-associated protein). The purpose of this study is to
analyze the renal distribution of ATRAP and to examine
whether ATRAP is co-expressed with the AT1 receptor in the
mouse kidney. We performed in situ hybridization, Western
blot analysis, and immunohistochemistry to investigate the
expression of ATRAP mRNA and protein in the mouse kidney.
The results of Western blot analysis revealed the ATRAP
protein to be abundantly expressed in the kidney. Employing
in situ hybridization and immunohistochemistry, we found
that both ATRAP mRNA and the protein were widely
distributed along the renal tubules from Bowman’s capsules
to the inner medullary collecting ducts. ATRAP mRNA was
also detected in the glomeruli, vasculature, and interstitial
cells. In all tubular cells, the ATRAP protein colocalized with
the AT1 receptor. Finally, we found that the dietary salt
depletion significantly decreased the renal expression of
ATRAP as well as AT1 receptor. These findings show ATRAP
to be abundantly and broadly distributed in nephron
segments where the AT1 receptor is expressed. Furthermore,
this is the first report demonstrating a substantial
colocalization of ATRAP and AT1 receptor in vivo.
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Angiotensin II (Ang II), a bioactive product of the
renin–angiotensin system (RAS), plays a central role in the
regulation of blood pressure and the maintenance of water-
electrolyte metabolism by direct effects on tubular reabsorp-
tion, constriction of blood vessels and stimulation of the
release of aldosterone. Ang II also contributes to the
pathogenesis of hypertension and cardiac hypertrophy, as
well as the development of renal inflammatory disease and
sclerosis. The angiotensin II type 1 (AT1) receptor is the main
receptor subtype responsible for these hemodynamic and
cardiovascular effects of Ang II and has been reported to be
distributed in many tissues, including the heart, brain, spleen,
testis, liver, artery, adrenal gland, and kidney.1,2
The AT1 receptor has a seven-transmembrane spanning
structure and belongs to the G protein-coupled receptor
family. The carboxyl-terminal cytoplasmic domain of the
AT1 receptor is important for receptor signaling, desensitiza-
tion and internalization.3,4 Employing a yeast two-hybrid
system screening of a mouse kidney cDNA library, we
previously cloned a novel protein, Angiotensin II Type 1
Receptor-Associated Protein (ATRAP), which interacts spe-
cifically with the carboxyl-terminal cytoplasmic domain of
the AT1 receptor.5 ATRAP is predicted to have a three-
transmembrane domain structure protein with a molecular
mass of 18 kDa and is localized to the plasma membrane and
intracellular trafficking vesicles in transfected cultured cells.6
Functionally, several in vitro studies showed that over-
expression of ATRAP induces the internalization of the AT1
receptor and decreases both the generation of inositol lipids
and cell proliferation, suggesting that ATRAP may be a
negative regulator for AT1 receptor signaling.6–8
In the present study, we developed a polyclonal anti-
ATRAP antibody and demonstrated that the ATRAP protein
is expressed abundantly in the kidney. We examined the
precise localization of the renal ATRAP expression at levels of
mRNA and protein by in situ hybridization and immuno-
histochemistry and determined whether the ATRAP protein
coincided with the AT1 receptor in the kidney. Furthermore,
we examined a possible effect of dietary salt restriction, which
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is known to activate circulating RAS, on the renal expression
of ATRAP protein.
RESULTS
Validation of the specificity of the antibody for ATRAP
Western blot analysis of ATRAP-transfected H9c2 cells
revealed that the antiserum for ATRAP recognized a
prominent band of 18 kDa, which was consistent with the
predicted molecular weight of ATRAP (Figure 1a). This band
was not observed when the antiserum was substituted with
the pre-immune serum (data not shown) or when empty
vector pcDNA3-transfected H9c2 cells were used instead of
ATRAP-transfected cells (Figure 1a). Furthermore, Western
blot analysis of in vitro translated FLAG-AT1R protein using
the ATRAP antibody showed that the ATRAP antibody did
not recognize the FLAG-AT1R protein (Figure 1b). These
data indicate that the ATRAP antibody is able to recognize
the ATRAP protein specifically but does not crossreact on the
AT1 receptor protein.
Expression of ATRAP protein in mouse tissues
By Western blot analysis, the ATRAP antibody detected a
major protein band at 18 kDa in the mouse kidney tissue and
this band was not observed when the antibody was
preabsorbed with a 10-fold excess of the peptide used to
generate the antibody (Figure 2a). The ATRAP protein was
also found to be widely expressed in many mouse tissues, as
was the AT1 receptor protein (Figure 2b). As shown in Figure
2b, the ATRAP protein was expressed at relatively high levels
in the kidney, lung and testis, followed by the spleen, but at
lower levels in the heart, brain, liver, skeletal muscles, and
aorta. In the kidney, the ATRAP protein was expressed more
highly in the medulla rather than in the cortex (Figure 2c).
In situ hybridization for ATRAP mRNA in the mouse kidney
We determined the distribution of ATRAP mRNA in kidney
sections from the normal adult mouse by in situ hybridization
using an ATRAP antisense cRNA probe. A high level of
ATRAP mRNA was observed in Bowman’s capsules (Figure
3a and b), the proximal convoluted tubules (PCT) (Figure
3a), the proximal straight tubules (PST) (Figure 3c), the
medullary thick ascending limbs (MTAL) (Figure 3c), the
distal convoluted tubules (DCT) (Figure 3a), the cortical
collecting ducts (CCD) (Figure 3a), and the outer medullary
collecting ducts (OMCD). In the glomeruli, Figure 3b shows
the positive staining in the podocytes and mesangial cells. A
lower level of ATRAP mRNA was observed in the inner
medullary collecting ducts (IMCD) (Figure 3d). Very weak
staining was observed in the vascular endothelial and smooth
muscle cells in the arcuate artery, interlobular arteries (Figure
3e) and arterioles. There was also very weak staining in the
interstitial cells. No labeling for ATRAP mRNA was found in
the negative control sections that were hybridized with the
sense probe (Figure 3f).
Immunohistochemistry for ATRAP protein in the mouse
kidney
Immunohistochemistry using the polyclonal anti-ATRAP
antibody within kidney sections from normal adult mouse
was performed. A relatively high level of ATRAP immuno-
reactivity was observed in Bowman’s capsules (Figure 4a), the
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Figure 1 | Specificity of the ATRAP antibody. (a) Western blot
analysis of transiently transfected H9c2 cells using the ATRAP
antiserum. Negative control, empty vector pcDNA3-transfected H9c2
cells; ATRAP, the mouse ATRAP in pcDNA3-transfected H9c2 cells;
HA-ATRAP, HA epitope-tagged ATRAP-transfected H9c2 cells.
(b) Western blot analysis of in vitro translated proteins using the
ATRAP antibody. HA-ATRAP, in vitro translated HA epitope-tagged
ATRAP protein; FLAG-AT1R, in vitro translated FLAG epitope-tagged
mouse AT1a receptor protein.
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Figure 2 | Western blot analysis of mouse tissues. (a) Western blot
analysis of mouse kidney protein using the ATRAP antibody. ATRAP,
the mouse ATRAP in pcDNA3-transfected H9c2 cells (1). (a) Western
blot analysis of mouse kidney protein using the ATRAP antibody
preabsorbed with a 10-fold excess of the peptide used to generate
the antibody (2). (b) Western blot analysis of many mouse tissue
proteins using the ATRAP antibody, with the expression of the AT1
receptor and the house keeping gene, b-actin, also presented for
comparison. (c) Western blot analysis of mouse renal cortex and
medulla using the ATRAP antibody, with the expression of the AT1
receptor and b-actin.
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PCT (Figure 4a), the PST (Figure 5a), and the DCT (Figure
4c). A lower level of ATRAP immunostaining was detected in
the MTAL (Figure 5c), the connecting tubules (CNT), the
CCD (Figure 4c), and the OMCD (Figure 5c). Only very
weak staining was observed in the IMCD (Figure 5e).
Significant staining was not found in the glomeruli (Figure
4a), in the vasculature, including arcuate artery (Figure 6a),
interlobular arteries, and arterioles, or in the interstitial cells.
No immunoreactivity of the ATRAP protein was found in the
negative control sections that were consecutive sections
incubated with preabsorption of the anti-ATRAP antibody
along with the competing antigenic peptide (Figure 4e) and
incubated with non-immune rabbit IgG (data not shown).
Colocalization of ATRAP with AT1 receptor in the mouse
kidney
Immunohistochemistry using the AT1 receptor antibody
within kidney sections from normal adult mouse was
performed. From the result of the present study, the intense
staining of the AT1 receptor was found in the vascular
smooth muscle cells of arcuate artery (Figure 6b), inter-
lobular arteries, and efferent and afferent arterioles. Higher
levels of AT1 receptor staining were found in the PST (Figure
5b), the DCT (Figure 4d), the CNT and the CCD (Figure 4d).
Relatively low levels of AT1 receptor staining were observed
in Bowman’s capsules (Figure 4b), the PCT (Figure 4b), the
MTAL (Figure 5d), the OMCD (Figure 5d), the IMCD
(Figure 5f), and the glomeruli (Figure 4b). The positive
staining was also detected in the interstitial cells.
In the consecutive sections stained for ATRAP and AT1
receptor, all ATRAP-immunopositive tubules expressed the
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Figure 3 | Localization of ATRAP mRNA by in situ hybridization in
the mouse kidney. (a) A cortical section showing expression of
ATRAP mRNA (positive staining purple) in the glomeruli, Bowman’s
capsule, the PCT (short arrow), the DCT (long arrow), and the CCD
(double arrows). (b) Higher magnification of the glomerulus showing
expression in mesangial cells (arrows) and podocytes (*). (c) The
outermedullary section showing expression in the PST (short arrow)
and the MTAL (long arrow). (d) An innermedullary section showing
expression in the IMCD (arrow). (e) The interlobular artery showing
only very weak expression in vascular endothelial and smooth muscle
cells. (f) A section hybridized with the ATRAP sense probe as a
negative control. Original magnification  400.
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Figure 4 | Immunohistochemical localization of ATRAP and AT1
receptor in the mouse renal cortex. (a and b) The consecutive
sections stained for ATRAP and AT1 receptor (arrow, the PCT). (c and
d) The consecutive sections stained for ATRAP and AT1 receptor
(short arrow, the DCT; double arrows, the CCD.). (e) The consecutive
section stained with ATRAP antibody preabsorbed with 10-fold
excess of immunizing peptide as a negative control. Original
magnification  400.
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AT1 receptor (Figures 4a–d and 5a–f). The intracellular
staining of both ATRAP and the AT1 receptor was found to
be homogeneous in the CNT, CCD and OMCD (Figures 4c, d
and 5c, d). The immunoreactivity of both proteins was
intense in the brush border region in the PCT (Figure 4a and
b). However, the intracellular distribution of ATRAP did not
completely coincide with that of the AT1 receptor, as in the
following tubular segments. In the PST, although the
immunoreactivity of AT1 receptor was intense in the brush
border (Figure 5b), ATRAP stained evenly (Figure 5a). In the
MTAL, although the immunoreactivity of AT1 receptor was
intense on the basal side (Figure 5d), ATRAP again stained
evenly (Figure 5c). In the DCT, although the immuno-
reactivity of AT1 receptor was intense on the basal side
(Figure 4d), the staining of ATRAP was intense on the apical
side (Figure 4c).
Effects of dietary salt depletion on protein expression
of ATRAP in the mouse kidney
The mean body weight of the mice fed a low-salt (LS) diet
(25.771.3 g, n¼ 4) was not significantly different from that
of the mice fed a normal salt (NS) diet (24.670.7 g, n¼ 4) at
the end of the experiment. Systolic blood pressure was not
significantly changed by an LS diet (129.379.6 mmHg,
n¼ 4) compared with an NS diet (116.076.2 mmHg,
n¼ 4). Renal expression of ATRAP and AT1 receptor proteins
in the mice consuming an LS or NS diet was determined by
Western blot analysis (Figure 7). Salt depletion led to a
decrease in the renal expression of the ATRAP protein
compared with an NS diet, as well as that of the AT1 receptor
protein.
DISCUSSION
In the present study, a polyclonal anti-ATRAP antibody was
prepared and that proved to be remarkably useful in the
analysis of the ATRAP protein. The ATRAP protein, as well as
the AT1 receptor, was found to be widely expressed in many
mouse tissues, although there was some dissociation of the
abundance of two proteins in each tissue. The ATRAP protein
is expressed highly in the kidney, as is ATRAP mRNA in vivo.5
Employing in situ hybridization and immunohistochem-
istry for ATRAP within the kidney sections, the renal ATRAP
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Figure 5 | Immunohistochemical localization of ATRAP and AT1
receptor in the mouse renal medulla. (a and b) The consecutive
sections from the outer medulla stained for ATRAP and AT1 receptor
(arrow, the PST.). (c and d) The consecutive sections from the outer
medulla stained for ATRAP and AT1 receptor (short arrow, the MTAL;
long arrow, the OMCD). (e and f) The consecutive sections from the
inner medulla stained for ATRAP and AT1 receptor (arrow, the IMCD).
Original magnification  400.
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Figure 6 | Immunohistochemical localization of ATRAP and AT1
receptor in the mouse renal vasculature. (a and b) The consecutive
sections from the arcuate artery for ATRAP and AT1 receptor. Original
magnification  400.
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Figure 7 | Effects of dietary salt depletion on ATRAP protein
expression in the mouse kidney. (a) Representative Western blot
analysis showing the expression of the ATRAP protein in the kidney
of mice fed an LS or NS diet, with the expression of the AT1 receptor
and the house keeping gene, b-actin, also presented for comparison.
(b) Relative ATRAP and AT1 receptor protein levels in the kidney of
mice fed an LS or NS diet were measured using NIH image. Results
are expressed as means7s.e. (n¼ 4 in each group).
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expression at levels of both mRNA and protein was widely
and abundantly distributed in the renal tubules from
Bowman’s capsules to the IMCD, but the relative abundance
of mRNA vs the protein differed in each nephron segment.
Furthermore, the expression of ATRAP mRNA was more
extensively detected in the glomeruli, vasculature and
interstitial cells than that of ATRAP protein. This result
may be due to a technical limitation of immunohistochem-
ical method, which is not able to detect lower levels of
protein expression. Actually, Western blot analysis, which was
more sensitive technique, could detect the expression of
ATRAP protein in the aorta and cultured mesangial cells
(Figure 2b and data not shown). It is possible that the levels
of ATRAP protein expression in the glomeruli, renal
vasculatures and interstitial cells were too low to detect by
immunohistochemical technique. It is also possible that
ATRAP may undergo post-transcriptional regulation.
Consistent with previous studies,9–12 the specific immu-
noreactivity of the AT1 receptor was observed along the
entire nephron in results reported here. From the immuno-
histochemical results of the present study, all ATRAP-
immunopositive tubules from Bowman’s capsules to the
IMCD expressed the AT1 receptor in the consecutive sections
stained for ATRAP and the AT1 receptor. However, there was
some dissociation of the abundance of two proteins in each
nephron segment, as the tissue distribution of two proteins.
The renal AT1 receptor expression at a level of protein was
more broadly found in the vasculature and glomeruli. Recent
studies indicate that interstitial Ang II plays a key role in the
regulation of the renal microcirculation and tubular function
and acts as an important mediator in the pathogenesis of
tubulointerstitial changes.13 In the present study, we observed
expression of AT1 receptor in the interstitial cells by
immunohistochemistry. With respect to expression of
ATRAP in the interstitial cells, in situ hybridization analysis
revealed a weak expression of ATRAP mRNA in the
interstitial cells, but immunohistochemical analysis could
not detect any significant staining for ATRAP protein in these
cells, suggesting that the expression of ATRAP is low in the
interstitial cells, at least in the baseline condition.
Furthermore, the intracellular localization of ATRAP also
does not completely coincide with that of the AT1 receptor in
several tubular segments. It is possible that some physiolo-
gical conditions that alter the activity of RAS may influence
both intrarenal and intracellular distribution of ATRAP in
vivo. Actually, we have recently shown that Ang II induces
colocalization of ATRAP and AT1 receptor in primary
cardiomyocytes.8 Some discrepancy of the intracellular
localization of ATRAP and AT1 receptor is also in agreement
with our previous immunoprecipitation experiments and
subcellular colocalization analysis in cultured cells that show
significant but not complete complex formation and
colocalization of these proteins,5,6,8 suggesting that ATRAP
and AT1 receptor can have other effectors as reported in a
recent study.14 Further molecular screens for both AT1
receptor and ATRAP will reveal the existence of additional
partners for these molecules that may act cooperatively or
independently both in time and in a specific cellular location
in the kidney. These questions are interesting, and our
laboratory is actively characterizing these interactions.
Interestingly, the expression of renal ATRAP protein was
significantly decreased by dietary salt depletion, concordantly
with AT1 receptor expression. Dietary salt depletion is
known to increase the components of RAS in the kidney,
to activate the circulating RAS15,16 and to decrease the
expression of renal AT1a receptor mRNA.17,18 The result
from the present study indicates that ATRAP as well as
AT1 receptor are regulated by the conditions that alter
the activity of RAS in vivo, suggesting that ATRAP expression
is modulated by several physiological and perhaps patho-
logical stimuli.
In the kidney, Ang II regulates both renal hemodynamics
and tubular transport. According to recent reports, Ang II
stimulates its precursor angiotensinogen in the proximal
tubular cells19,20 and epithelial sodium channel activity in the
cortical collecting duct.21,22 Ang II also has certain non-
hemodynamic effects that include stimulating extracellular
matrix synthesis,23 inducing cell proliferation,24,25 and
inducing renal cell hypertrophy.26,27 Ang II exerts a number
of hemodynamic and non-hemodynamic effects on renal cells
so as to contribute to the progression of glomerular sclerosis
and tubulointerstitial fibrosis. Our studies demonstrate that
ATRAP is expressed along the entire nephron segments, as is
the AT1 receptor, and ATRAP is abundantly expressed
especially in renal tubules. Limitations of the present study
include the lack of immunofluorescent colocalization analysis
with double staining of ATRAP and AT1 receptor using the
multiple fluorolabeling method and confocal laser micro-
scopy, and the lack of functional study of renal tubular
ATRAP. The precise functions of ATRAP in each nephron
segment remain to be determined, but the results do imply
that ATRAP could well have a role in both the physiological
and pathophysiological functioning of the intrarenal RAS via
a modulation of AT1 receptor signaling, mainly in renal
tubules. Further studies will be needed to elucidate the
function of ATRAP in the kidney, and will be taken up in due
course.
CONCLUSION
This study demonstrates the abundant expression of ATRAP
mRNA and protein and their distribution in the kidney.
ATRAP is broadly distributed along the nephron, and this is
the first report demonstrating a substantial colocalization of
ATRAP and AT1 receptor in vivo.
MATERIALS AND METHODS
Animals
Adult male C57BL/6J mice (8–12 weeks), which were housed under a
12/12 h day/night cycle at a temperature of 251C and given free
access to tap water and fed a standard pellet diet, were used for the
present study. For the salt depletion study, 8-week-old mice were
placed on an LS (0.02% NaCl, n¼ 4) or an NS (0.3% NaCl, n¼ 4)
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diet for 2 weeks. Systolic blood pressure was measured by a tail cuff
method (BP-monitor MK-2000; Muromachi Kikai Co., Tokyo,
Japan). Following experimental treatment, the mice were anesthe-
tized and the tissues were removed into liquid nitrogen or fixative.
Transient transfection/in vitro translation
The immortalized cell line H9c2, which expresses endogenous AT1
receptor, was cultured as described previously.28 The mouse ATRAP
in pcDNA3 (pc-ATRAP), the NH2-terminal HA epitope-tagged
ATRAP5 in pcDNA3 (pHA-ATRAP), or an empty vector pcDNA3
was transiently transfected into H9c2 cells according to the
PolyFECT protocol (Qiagen, Hilden, Germany). Forty-eight hours
after the transfection, whole cellular extracts were prepared from the
transfected cells.6
The FLAG epitope-tagged mouse AT1a receptor in pcDNA3.1
(pFLAG-AT1R) and pHA-ATRAP were in vitro translated using
TNTTM kit (Promega, WI, USA) in the absence of 35S-methionine
according to the manufacturer’s instructions.
Production of rabbit anti-ATRAP antibody
A 14-aa synthetic peptide corresponding to amino acids 148–161 of
the carboxyl-terminal tail of the mouse ATRAP was produced using
standard solid-phase peptide synthesis techniques. Analysis using
the BLAST computer program showed no significant overlap of the
immunizing peptide with any known eukaryotic protein. The
peptide was purified, conjugated, and injected three times
intradermally into rabbits at 2-week intervals for production of
the polyclonal antiserum. The rabbits developed enzyme-linked
immunosorbent assay titers 41:128 000 before exsanguination. The
selectivity of the antiserum was validated by the recognition of pc-
ATRAP- or pHA-ATRAP-transfected H9c2 cells by Western blot
analysis. Anti-ATRAP polyclonal antibodies were affinity-purified.
Western blot analysis
The mouse tissue extracts (100 mg per lane), whole cellular extracts
(20mg per lane) from cultured cells or in vitro translated products
(15ml per lane) were loaded on 12% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis gels and transferred to poly-
vinylidene difluoride membranes (Millipore, MA, USA), which were
blocked with phosphate-buffered saline that contained 5% skim
milk powder. The membranes were incubated with either (1)
ATRAP antibody diluted at 1:1000 or (2) the rabbit polyclonal
affinity-purified anti-AT1 receptor antibody (AT1 (N-10), sc-1173,
Santa Cruz Biotechnology Inc, CA, USA) that is raised against N-
terminal extracellular domain of AT1 receptor of human origin and
crossreacts on mouse AT1 receptor, diluted at 1:1000. The
membranes were washed and incubated with the goat anti-rabbit
IgG conjugated to horseradish peroxidase (Amersham Biosciences,
NJ, USA) diluted at 1:1500. Sites of antibody–antigen reaction were
visualized by enhanced chemiluminescence (Amersham Biosciences,
NJ, USA) and placed on film. The images were analyzed by
densitometry using NIH image (NIH).
Immunohistochemistry for ATRAP and AT1 receptor within
the mouse kidney
The kidneys were perfusion-fixed with 4% paraformaldehyde,
subsequently embedded in paraffin, and sectioned at 4 mm thickness.
The sections were dewaxed and rehydrated. Antigen retrieval was
performed by microwave heating. The sections were treated for
60 min with 10% normal goat serum in phosphate-buffered saline
and blocked for endogenous biotin activity using AVIDIN/BIOTIN
Blocking kit (Vector Laboratories, CA, USA). For the study of
ATRAP, the sections were incubated at 41C overnight with one of the
following diluted in phosphate-buffered saline: (1) ATRAP antibody
diluted at 1:100, (2) ATRAP antibody preabsorbed with a 10-fold
excess of the peptide used to generate the antibody, (3) non-immune
rabbit IgG. For the study of AT1 receptor, the sections were
incubated at 41C overnight with either; (1) AT1 receptor antibody
(Santa Cruz Biotechnology Inc, CA, USA) diluted at 1:100 or (2)
non-immune rabbit IgG. The sections were incubated for 60 min
with the biotinylated goat anti-rabbit IgG (Nichirei Corporation,
Tokyo, Japan), blocked for endogenous peroxidase activity by
incubation with 0.3% H2O2 for 20 min, treated for 30 min
with the streptavidin and biotinylated peroxidase (DAKO, Heidel-
berg, Germany), and then exposed to diaminobenzidine. The
sections were counterstained with hematoxylin, dehydrated, and
mounted.
In situ hybridization for ATRAP within the mouse kidney
The kidneys were perfusion-fixed with 4% paraformaldehyde,
subsequently embedded in paraffin and sectioned. The riboprobes
were generated complementary to the full length of mouse
ATRAP cDNA fragments (483 bases). Digoxigenin-labeled antisense
and sense probes were prepared by the transcription of linearized
mouse ATRAP cDNA in a pcDNA3.1 vector (Invitrogen, CA,
USA) using a digoxigenin RNA labeling kit (Roche, Basel,
Switzerland). In situ hybridization was performed, as described.29,30
Hybridized digoxigenin-labeled probes were detected using
anti-digoxigenin-alkaline phosphatase conjugate. The probe was
visualized using 4-nitroblue tetrazolium chloride and 5-bromo-4-
chloro-3-indolylphosphate.
Statistical analysis
Data are expressed as mean7s.e. Statistical significance was
determined by unpaired Student’s t-test, with Po0.05 being deemed
statistically significant.
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